CORONA Remedies commercialises women's hormone manufacturing facility in Ahmedabad
India, June 30 -- CORONA Remedies has announced the inauguration and commercialisation of its dedicated EU-GMP approved Hormone Manufacturing Facility at Bhayla, Ahmedabad. The facility marks a significant milestone in the company's journey towards building globally benchmarked pharmaceutical manufacturing capabilities.
Published by HT Digital Content Services with permission from BioSpectrum India....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.